Quantics Biostatistics — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Quantics Biostatistics is a UK-based, independent consultancy that provides high-level statistical analysis and software for the life sciences sector. Its core offerings include regulatory-compliant biostatistics for bioassays, clinical trials, pharmacokinetics/pharmacodynamics (PK/PD), and health economics, supported by its proprietary QuBAS analysis platform. With unique credentials as an MHRA-licensed GLP test site and ISO9001 accreditation, the company positions itself as a trusted partner for pharmaceutical, biotech, and medical device companies navigating complex regulatory pathways. Its business model is entirely service and software-oriented, generating revenue through client projects.

Digital HealthAI / Machine Learning

Technology Platform

Proprietary QuBAS software for bioassay analysis, combined with deep expertise in advanced statistical methodologies for clinical trials, PK/PD, and HTA submissions.

Opportunities

Growth is driven by increasing complexity in drug development (e.g., biologics, cell therapies) and heightened regulatory/HTA demands, creating need for specialized statistical expertise.

Expansion of its QuBAS software platform and services into adjacent areas like real-world evidence and advanced modeling presents further avenues for growth.

Risk Factors

Key risks include reliance on a limited number of expert personnel, vulnerability to cyclical shifts in client R&D spending, and intense competition from both large CROs and niche consultancies.

Staying ahead of evolving regulatory guidelines is a constant operational challenge.

Competitive Landscape

Quantics competes in a fragmented market against large, full-service Contract Research Organizations (CROs) and other specialized biostatistics consultancies. Its key differentiators are its unique MHRA GLP test facility certification, ISO9001 accreditation, and deep niche expertise in bioassay and HTA statistics, which allow it to compete on quality and regulatory assurance rather than scale alone.

More companies in United Kingdom →